Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
- 20 March 2008
- Vol. 26 (13) , 1644-1651
- https://doi.org/10.1016/j.vaccine.2008.01.025
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine DesignJournal of Virology, 2006
- Intranasal Vaccination with Recombinant Adeno-Associated Virus Type 5 against Human Papillomavirus Type 16 L1Journal of Virology, 2006
- Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus ImmunizationJournal of Virology, 2005
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccinesVaccine, 2005
- SARS Vaccine DevelopmentEmerging Infectious Diseases, 2005
- Differential contributions of central and effector memory T cells to recall responsesThe Journal of Experimental Medicine, 2005
- SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirusVaccine, 2005
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- SARS Experts Want Labs to Improve Safety PracticesScience, 2003